Citations

Showing 10 of 108135 citations.

Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C
Kawles, Allegra , Nishihira, Yasushi, Gill, Nathan , Minogue, Grace , Keszycki, Rachel , Coventry, Christina , Spencer, Callen, Lilek, Jaclyn , Ajroud, Kaouther , Coppola, Giovanni , Rademakers, Rosa , Rogalskı, Emily , Weıntraub, Sandra , Zhang, Hui , Flanagan, Margaret E. , Bigio, Eileen H. , Mesulam, M.‐Marsel, Geula, Changiz , Gefen, Tamar , Coventry, Christina , Rademakers, Rosa , Weintraub, Sandra , Mesulam, M-Marsel , Feldman, Alex, Mao, Qinwen , Flanagan, Margaret E

Mayo Clinic

Brain | September 30, 2021 | Volume: 145 | Issue: 3 | Pages: 1069-1078

10.1093/brain/awab368 | PMID 34919645 Get It

Abstract The TDP-43 type C pathological form of frontotemporal lobar degeneration is characterized by the presence of immunoreactive TDP-43 short and long dystrophic neurites, neuronal cytoplasmic inclusions, neuronal loss and gliosis and the absence of neuronal intranuclear inclusions. Frontotemporal lobar degeneration-TDP-type C cases are commonly associated with the semantic variant of primary progressive aphasia or behavioural variant frontotemporal dementia. Here, we provide detailed characterization of regional distributions of pathological TDP-43 and neuronal loss and gliosis in cortical and subcortical regions in 10 TDP-type C cases and investigate the relationship between inclusions and neuronal loss and gliosis. Specimens were obtained from the first 10 TDP-type C cases accessioned from the Northwestern Alzheimer’s Disease Research Center (semantic variant of primary progressive aphasia, n = 7; behavioural variant frontotemporal dementia, n = 3). A total of 42 cortical (majority bilateral) and subcortical regions were immunostained with a phosphorylated TDP-43 antibody and/or stained with haematoxylin–eosin. Regions were evaluated for atrophy, and for long dystrophic neurites, short dystrophic neurites, neuronal cytoplasmic inclusions, and neuronal loss and gliosis using a semiquantitative 5-point scale. We calculated a ‘neuron-to-inclusion’ score (TDP-type C mean score – neuronal loss and gliosis mean score) for each region per case to assess the relationship between TDP-type C inclusions and neuronal loss and gliosis. Primary progressive aphasia cases demonstrated leftward asymmetry of cortical atrophy consistent with the aphasic phenotype. We also observed abundant inclusions and neurodegeneration in both cortical and subcortical regions, with certain subcortical regions emerging as particularly vulnerable to dystrophic neurites (e.g. amygdala, caudate and putamen). Interestingly, linear mixed models showed that regions with lowest TDP-type C pathology had high neuronal dropout, and conversely, regions with abundant pathology displayed relatively preserved neuronal densities (P < 0.05). This inverse relationship between the extent of TDP-positive inclusions and neuronal loss may reflect a process whereby inclusions disappear as their associated neurons are lost. Together, these findings offer insight into the putative substrates of neurodegeneration in unique dementia syndromes.
Development and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules
Ospina, Naykky Singh , Bagautdinova, Diliara , Hargraves, Ian , Barb, Diana , Subbarayan, Sreevidya, Srihari, Ashok, Bylund, Carma L. , Treise, Debbie, Brito, Juan P. , Ospina, Naykky Singh , Barb, Diana , Singh Ospina, Naykky M , Singh Ospina, Naykky , Brito, Juan P , Wang, Shu , Maraka, Spyridoula , Montori, Víctor M.

Mayo Clinic

Clinical Endocrinology | September 30, 2021 | Volume: 96 | Issue: 4 | Pages: 627-636

10.1111/cen.14599 | PMID 34590734 Get It

AbstractObjectiveTo support patient‐centred care and the collaboration of patients and clinicians, we developed and pilot tested a conversation aid for patients with thyroid nodules.Design, Patient and MeasurementsWe developed a web‐based Thyroid NOdule Conversation aid (TNOC) following a human‐centred design. A proof of concept observational pre–post study was conducted (TNOC vs. usual care [UC]) to assess the impact of TNOC on the quality of conversations. Data sources included recordings of clinical visits, post‐encounter surveys and review of electronic health records. Summary statistics and group comparisons are reported.ResultsSixty‐five patients were analysed (32 in the UC and 33 in the TNOC cohort). Most patients were women (89%) with a median age of 57 years and were incidentally found to have a thyroid nodule (62%). Most thyroid nodules were at low risk for thyroid cancer (71%) and the median size was 1.4 cm. At baseline, the groups were similar except for higher numeracy in the TNOC cohort. The use of TNOC was associated with increased involvement of patients in the decision‐making process, clinician satisfaction and discussion of relevant topics for decision making. In addition, decreased decisional conflict and fewer thyroid biopsies as the next management step were noted in the TNOC cohort. No differences in terms of knowledge transfer, length of consultation, thyroid cancer risk perception or concern for thyroid cancer diagnosis were found.ConclusionIn this pilot observational study, using TNOC in clinical practice was feasible and seemed to help the collaboration of patients and clinicians.
A Pilot Study to Estimate the Impact of High Matrix Image Reconstruction on Chest Computed Tomography
Johnson, Tucker F. , Voß, Benjamin, Lee, Yong S. , Koo, Chi Wan , McCollough, Brian, Weaver, Jayse , Gong, Hao , Carter, Rickey E. , Inoue, Akitoshi , Voss, Benjamin A, McCollough, Brian D, Weaver, Jayse M, Carter, Rickey E , Leng, Shuai , McCollough, Cynthia H. , Fletcher, Joel G.

Mayo Clinic

Journal of Clinical Imaging Science | September 30, 2021 | Volume: 11 | Issue: No issue available | Pages: 52

10.25259/jcis_143_2021 | PMID 34621597 Get It

Objectives: The objectives of the study were to estimate the impact of high matrix image reconstruction on chest computed tomography (CT) compared to standard image reconstruction. Material and Methods: This retrospective study included patients with interstitial or parenchymal lung disease, airway disease, and pulmonary nodules who underwent chest CT. Chest CT images were reconstructed using high matrix (1024 × 1024) or standard matrix (512 × 512), with all other parameters matched. Two radiologists, blinded to reconstruction technique, independently examined each lung, viewing image sets side by side and rating the conspicuity of imaging findings using a 5-point relative conspicuity scale. The presence of pulmonary nodules and confidence in classification of internal attenuation was also graded. Overall image quality and subjective noise/artifacts were assessed. Results: Thirty-four patients with 68 lungs were evaluated. Relative conspicuity scores were significantly higher using high matrix image reconstruction for all imaging findings indicative of idiopathic lung fibrosis (peripheral airway visualization, interlobular septal thickening, intralobular reticular opacity, and end-stage fibrotic change; P ≤ 0.001) along with emphysema, mosaic attenuation, and fourth order bronchi for both readers (P ≤ 0.001). High matrix reconstruction did not improve confidence in the presence or classification of internal nodule attenuation for either reader. Overall image quality was increased but not subjective noise/artifacts with high matrix image reconstruction for both readers (P < 0.001). Conclusion: High matrix image reconstruction significantly improves the conspicuity of imaging findings reflecting interstitial lung disease and may be useful for diagnosis or treatment response assessment.
Case series: MRD negativity assessment using 11 C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma
Ngai, Cheong , Kumar, Shaji , Ho, Garrett C. L., Chen, Sirong , Chim, Chor Sang

Mayo Clinic

Therapeutic Advances in Hematology | September 30, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/20406207211030369 | PMID 34616538 Get It

Complete response (CR) is an important favorable factor for survival in multiple myeloma (MM). However, CR patients continue to relapse, especially in the presence of minimal residual disease (MRD). Bone marrow (BM) MRD is predictive of progression-free survival (PFS) in MM. However, myeloma outside the BM aspiration site may result in subsequent relapse despite MRD-negativity. Therefore, positron emission tomography-computed tomography (PET-CT) based on F-fluorodeoxyglucose (FDG) is a complementary tool to monitor residual disease in MM. However, FDG may miss myeloma lesions that are not FDG-avid. On the other hand, 11 C-Acetate (ACT) has been found to be a more sensitive and specific tracer than FDG in MM. Recently, the addition of daratumumab to bortezomib, thalidomide, dexamethasone (VTd) or bortezomib, lenalidomide, dexamethasone (VRd) backbone has been proven to improve outcomes. Herein, we report three newly-diagnosed MM patients achieving deep responses with imaging CR using ACT PET in addition to conventional immunofixation CR and MRD-negative CR after a 3-weekly daratumumab-based quadruplet induction regimen.
Defining Proximity Proteome of Histone Modifications by Antibody-Mediated Protein A-APEX2 Labeling
Li, Xinran , Zhou, Jiaqi , Zhao, Wenjuan , Wen, Qing , Wang, Weijie , Peng, Huipai , Gao, Yuan , Bouchonville, Kelly J. , Offer, Steven M. , Chan, Kui Ming , Wang, Zhiquan , Li, Nan , Gan, Haiyun , Offer, Steven M , Wang, Zhiquan

Mayo Clinic

Genomics, Proteomics & Bioinformatics | September 30, 2021 | Volume: 20 | Issue: 1 | Pages: 87-100

10.1016/j.gpb.2021.09.003 | PMID 34555496 Get It

Abstract Proximity labeling catalyzed by promiscuous enzymes, such as APEX2, has emerged as a powerful approach to characterize multiprotein complexes and protein–protein interactions. However, current methods depend on the expression of exogenous fusion proteins and cannot be applied to identify proteins surrounding post-translationally modified proteins. To address this limitation, we developed a new method to label proximal proteins of interest by antibody-mediated protein A-ascorbate peroxidase 2 (pA-APEX2) labeling (AMAPEX). In this method, a modified protein is bound in situ by a specific antibody, which then tethers a pA-APEX2 fusion protein. Activation of APEX2 labels the nearby proteins with biotin; the biotinylated proteins are then purified using streptavidin beads and identified by mass spectrometry. We demonstrated the utility of this approach by profiling the proximal proteins of histone modifications including H3K27me3, H3K9me3, H3K4me3, H4K5ac, and H4K12ac, as well as verifying the co-localization of these identified proteins with bait proteins by published ChIP-seq analysis and nucleosome immunoprecipitation. Overall, AMAPEX is an efficient method to identify proteins that are proximal to modified histones.
Systematic review with meta‐analysis: the prevalence of post‐colonoscopy colorectal cancers using the World Endoscopy Organization nomenclature
Kang, James , Evans, Nicole, Singh, Siddharth , Samadder, N. Jewel , Lee, Jeffrey K. , Kang, James H-E , Samadder, Niloy J

Mayo Clinic

Alimentary Pharmacology & Therapeutics | September 30, 2021 | Volume: 54 | Issue: 10 | Pages: 1232-1242

10.1111/apt.16622 | PMID 34587323 Get It

SummaryIntroductionPost‐colonoscopy colorectal cancers (PCCRCs) have been proposed as a performance metric for colonoscopy quality assurance programs. Previously, there was no standardised terminology or reporting methods. In 2018, the World Endoscopy Organization (WEO) advised standardised definitions and prevalence calculation methodology.AimsTo assess PCCRC burden using WEO standardised methods, to explore causes of heterogeneity, and to review changes in prevalence over timeMethodsWe updated a prior systematic review by searching Ovid MEDLINE and EMBASE databases from 1 January 2013 to 31 January 2021 to identify population‐based studies (or multicentre studies representative of the local population) reporting PCCRC prevalence (PROSPERO [CRD42020183796]). Two authors independently determined study eligibility, assessed quality, and extracted data. We estimated the PCCRC 3‐year prevalence using WEO‐recommended methodologies and investigated between‐study sources of heterogeneity. We examined changes in prevalence over time.ResultsFifteen studies reporting on 25 872 PCCRC cases met eligibility criteria. Pooled PCCRC 3 year prevalence was 8.2% (95% CI = 6.9%‐9.4%, I2 = 98.2%) across four European studies using WEO precise methodology. Proximal PCCRC prevalence was greater than distal (9.7% [95% CI = 7.0%‐12.4%] vs 5.4% [95% CI = 2.9%‐7.8%], I2 = 99.2%). Seven studies reporting PCCRC rates over time showed no consistent trend: four showed a decrease, one an increase and two were unchanged. Between‐study heterogeneity was high.ConclusionsPooled 3‐year PCCRC prevalence was 8.2% (95% CI = 6.9%‐9.4%). Despite WEO standardised methodology to define and calculate PCCRC rates, there was significant heterogeneity among studies. Comparing rates between populations remains challenging and additional studies are needed to better understand the global PCCRC burden to inform quality assurance programs.
Challenges Related to Surgical Site Infection Prevention—Results after Standardized Bundle Implementation
Jurt, Jonas, Hübner, Martin , Clerc, Daniel , Curchod, P, Aziz, Mohamed A. Abd El , Senn, Laurence , Demartines, Nicolas , Grass, Fabian , Abd El Aziz, Mohamed A , Demartines, N , Grass, F , Hübner, Martin , Hahnloser, Dieter

Mayo Clinic

Journal of Clinical Medicine | September 30, 2021 | Volume: 10 | Issue: 19 | Pages: 4524

10.3390/jcm10194524 | PMID 34640542 Get It

Aim: The aim of this study was to assess the implementation of an intraoperative standardized surgical site infection (SSI) prevention bundle. Methods: The multimodal, evidence-based care bundle included nine intraoperative items (antibiotic type, timing, and re-dosing; disinfection; induction temperature control > 36.5°; glove change; intra-cavity lavage; wound protection; and closure strategy). The bundle was applied to all consecutive patients undergoing colonic resections. The primary outcome, SSI, was independently assessed by the National Infection Surveillance Committee for up to 30 postoperative days. A historical, institutional pre-implementation control group (2012–2017) with an identical methodology was used for comparison. Findings: In total, 1516 patients were included, of which 1256 (82.8%) were in the control group and 260 (17.2%) were in the post-implementation group. After 2:1 propensity score matching, the groups were similar for all items (p > 0.05). Overall compliance with the care bundle was 77% (IQR 77–88). The lowest compliance rates were observed for temperature control (53% overall), intra-cavity lavage (64% overall), and wound protection and closure (68% and 63% in the SSI group, respectively). Surgical site infections were reported in 58 patients (22.2%) vs. 21.4% in the control group (p = 0.79). Infection rates were comparable throughout the Centers for Disease Control and Prevention (CDC) categories: superficial, 12 patients (4.5%) vs. 4.2%, p = 0.82; deep incisional, 10 patients (3.7%) vs. 5.1%, p = 0.34; organ space, 36 (14%) vs. 12.4%, p = 0.48. After propensity score matching, rates remained comparable throughout all comparisons (all p > 0.05). Conclusions: The implementation of an intraoperative standardized care bundle had no impact on SSI rates. This may be explained by insufficient compliance with the individual measures.
Chronic non‐healing facial ulcer: Trigeminal trophic syndrome from underlying paraneoplastic antibodies
Berry, Nicholas A. , Kumar, Anagha , Wetter, David A. , Kumar, Anagha B

Mayo Clinic

International Journal of Dermatology | September 29, 2021 | Volume: 61 | Issue: 11 | Pages: No page available

10.1111/ijd.15918 | PMID 34587279 Get It

Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review
Mufti, Asfandyar , Maliyar, Khalad , Alavi, Afsáneh , Sachdeva, Muskaan , Mufti, Asfandyar , Maliyar, Khalad , Alavi, A , Kim, Patrick , Sibbald, Cathryn

Mayo Clinic

Journal of Cutaneous Medicine and Surgery | September 29, 2021 | Volume: 26 | Issue: 2 | Pages: 176-180

10.1177/12034754211049711 | PMID 34587768 Get It

Background There is currently at least 1 biologic (adalimumab) approved in North America for treatment of Hidradenitis Suppurativa in the pediatric population. However, no reviews or clinical trials have specifically analyzed the effectiveness and safety data of biologic use in this population. The objective of this systematic review is to identify and summarize the outcomes of biologic therapy in pediatric patients with HS. Methods MEDLINE and EMBASE databases were used to conduct the search on Sept 18, 2020. Results The 15 included studies consisted of 26 patients, with the mean age of 15 ± 2.3 years. Females accounted for 53.8% ( n = 14/26) of cases. The mean duration of HS prior to biologic initiation was 3.5 ± 2.9 years, with the majority having Hurley Stage II. The 26 patients received 34 biologics in total: 85.3% treated with TNF alpha inhibitors (adalimumab n = 17, infliximab n = 10, etanercept n = 1, unspecified n = 1), 5.9% with IL-12/23 inhibitors (ustekinumab n = 2), 5.9% with IL-1 inhibitors (i.e., anakinra n = 2) and 2.9% received IL-23 inhibitors (i.e., guselkumab n = 1) biologics. Of the 26 patients, 23.1% ( n = 6/26) experienced complete resolution (CR), 73.1% ( n = 19/26) experienced partial resolution (PR), and 3.8% ( n = 1/26) had no resolution outcomes reported. The time to resolution of HS lesions after biologic initiation ranged from 10 days to 11.5 months (mean: 5.1 months). No adverse events were reported in the studies. Conclusion Although anti-TNF alpha were the most common biologics used for HS in pediatric cases, large-scale trials specific to pediatric patients with HS are needed to confirm these findings.
Association of race/ethnicity and socioeconomic status with COVID‐19 30‐day mortality at a Philadelphia medical center using a retrospective cohort study
Cheney-Peters, Dianna , Lee, Crystal Y., Mitsuhashi, Shuji , Zaret, Dina, Riley, Joshua M. , Venkataraman, Chantel M., Schaefer, Joseph , George, Brandon , Li, Chris J. , Smaltz, Christa, Bradley, Conor G., Fitzpatrick, Danielle M., Ney, David B., Chalikonda, Divya, Mairose, Joshua D., Chauhan, Kashyap , Szot, Margaret V., Jones, Robert B. , Bashir‐Hamidu, Rukaiya, Kubey, Alan , Kubey, Alan A , Jones, Robert B.

Mayo Clinic

Journal of Medical Virology | September 29, 2021 | Volume: 94 | Issue: 3 | Pages: 906-917

10.1002/jmv.27365 | PMID 34585772 Get It

AbstractCOVID‐19 has disproportionately affected low‐income communities and people of color. Previous studies demonstrated that race/ethnicity and socioeconomic status (SES) are not independently correlated with COVID‐19 mortality. The purpose of our study is to determine the effect of race/ethnicity and SES on COVID‐19 30‐day mortality in a diverse, Philadelphian population. This is a retrospective cohort study in a single‐center tertiary care hospital in Philadelphia, PA. The study includes adult patients hospitalized with polymerase‐chain‐reaction‐confirmed COVID‐19 between March 1, 2020 and June 6, 2020. The primary outcome was a composite of COVID‐19 death or hospice discharge within 30 days of discharge. The secondary outcome was intensive care unit (ICU) admission. The study included 426 patients: 16.7% died, 3.3% were discharged to hospice, and 20.0% were admitted to the ICU. Using multivariable analysis, race/ethnicity was not associated with the primary nor secondary outcome. In Model 4, age greater than 75 (odds ratio [OR]: 11.01; 95% confidence interval [CI]: 1.96–61.97) and renal disease (OR: 2.78; 95% CI: 1.31–5.90) were associated with higher odds of the composite primary outcome. Living in a “very‐low‐income area” (OR: 0.29; 95% CI: 0.12–0.71) and body mass index (BMI) 30–35 (OR: 0.24; 95% CI: 0.08–0.69) were associated with lower odds of the primary outcome. When controlling for demographics, SES, and comorbidities, race/ethnicity was not independently associated with the composite primary outcome. Very‐low SES, as extrapolated from census‐tract‐level income data, was associated with lower odds of the composite primary outcome.